Artificial Intelligence (AI) in Diagnostics Market Forecast Report 2032: Driving Efficiency, Reducing Costs, and Shaping the Future of Clinical Research

DelveInsight's Artificial Intelligence (AI) in Diagnostics Market Insights Report 2032 provides the current and forecast market analysis, individual leading Artificial Intelligence (AI) in Diagnostics Companies market shares, challenges, Artificial Intelligence (AI) in Diagnostics Market Drivers, barriers, trends, and key market Artificial Intelligence (AI) in Diagnostics companies in the market.

To read more about the latest highlights related to the Artificial Intelligence (AI) in Diagnostics Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/ai-in-diagnostics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Artificial Intelligence (AI) in Diagnostics Market Report
• In April 2025, Roche announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation for its VENTANA® TROP2 (EPR20043) RxDx Device. This marks the first Breakthrough Device Designation granted for a computational pathology companion diagnostic (CDx) device.
• In April 2025, Avant Technologies, Inc. and its JV partner, Ainnova Tech, Inc., announced that the U.S. Food and Drug Administration (FDA) is reviewing their submission package for a pre-submission meeting regarding Avant's VisionAI platform technology. The technology aims to revolutionize early disease detection using artificial intelligence (AI).
• In April 2025, Proprio announced FDA 510(k) clearance for its Paradigm AI surgical guidance platform to include intraoperative measurements, enabling the first-ever real-time 3D, dynamic, and segmental anatomical viewing and measurement during surgery.
• The AI in Diagnostics market was valued at USD 1,623.20 million in 2024, growing at a CAGR of 22.31% during the forecast period from 2025 to 2032 to reach USD 8,081.97 million by 2032.
• North America is projected to hold the largest share of the Artificial Intelligence (AI) in Diagnostics market in 2024, driven by several key factors.
• The leading Artificial Intelligence (AI) in Diagnostics Companies such as Aidoc, Owkin, Inc., Siemens Healthineers, PathAI, Ibex, Owkin, Inc., Imagen Technologies, Aiforia, RADLogics, Terarecon, Inc., Prenosis, Inc., Ibex, Google LLC, GE HealthCare, DreaMed, Riverain Technologies, Terarecon, Inc., Aiforia, RADLogics, and others.

To know more about why North America is leading the market growth in the Artificial Intelligence (AI) in Diagnostics Market, get a snapshot @ Artificial Intelligence (AI) in Diagnostics Market Outlook- https://www.delveinsight.com/sample-request/ai-in-diagnostics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Artificial Intelligence (AI) in Diagnostics Market Dynamics
According to the data provided by the World Health Organization, in 2023, globally, an estimated 39.9 million people were living with HIV and approximately 1.3 million population acquired HIV. Additionally, as per the same source, in 2023, approximately 10.8 million people fell ill with tuberculosis (TB). AI in Diagnostics is boosting the management of TB and HIV by enabling early detection and efficient monitoring. In TB, AI analyzes chest X-rays and CT scans to identify infection patterns, reducing reliance on radiologists, especially in low-resource areas. For HIV, AI supports disease progression tracking, treatment prediction, and detection of co-infections. These capabilities streamline workflows, reduce diagnostic delays, and enhance large-scale screening efforts.

Artificial Intelligence (AI) in Diagnostics Market Segmentation Analysis
AI in Diagnostics Market by Component (Hardware/software, and Services), Application (Infectious Disease Diagnostics, Radiology, Oncology, Cardiology, and Others), Technology (Machine Learning, Natural Language Processing, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Get a sneak peek at the Artificial Intelligence (AI) in Diagnostics Market Dynamics @ Artificial Intelligence (AI) in Diagnostics Market Dynamics Analysis- https://www.delveinsight.com/sample-request/ai-in-diagnostics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Artificial Intelligence (AI) in Diagnostics Companies
Aidoc, Owkin, Inc., Siemens Healthineers, PathAI, Ibex, Owkin, Inc., Imagen Technologies, Aiforia, RADLogics, Terarecon, Inc., Prenosis, Inc., Ibex, Google LLC, GE HealthCare, DreaMed, Riverain Technologies, Terarecon, Inc., Aiforia, RADLogics, and others.

Artificial Intelligence (AI) in Diagnostics Market Drivers
The AI in Diagnostics market is driven by the rising prevalence of infectious and chronic diseases. Simultaneously, the growing adoption of digital health and imaging technologies provides a strong foundation for integrating AI tools into existing healthcare workflows, improving efficiency and accuracy. Additionally, increased product development activities by key Artificial Intelligence in Diagnostics companies across the globe fueled by advancements in machine learning and growing regulatory support are expanding the availability of AI-powered diagnostic solutions.

Which MedTech key players in the Artificial Intelligence (AI) in Diagnostics Market are set to emerge as the trendsetter explore @ Artificial Intelligence (AI) in Diagnostics Companies- https://www.delveinsight.com/sample-request/ai-in-diagnostics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Artificial Intelligence (AI) in Diagnostics Market Report
• Coverage- Global
• Forecast Period- 2025-2032
• Artificial Intelligence (AI) in Diagnostics Companies- Aidoc, Owkin, Inc., Siemens Healthineers, PathAI, Ibex, Owkin, Inc., Imagen Technologies, Aiforia, RADLogics, Terarecon, Inc., Prenosis, Inc., Ibex, Google LLC, GE HealthCare, DreaMed, Riverain Technologies, Terarecon, Inc., Aiforia, RADLogics, and others.

Interested in knowing the Artificial Intelligence (AI) in Diagnostics Market by 2032? Click to get a snapshot of the Artificial Intelligence (AI) in Diagnostics Market Trends- https://www.delveinsight.com/sample-request/ai-in-diagnostics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Contents
1. Artificial Intelligence (AI) in Diagnostics Market Report Introduction
2. Artificial Intelligence (AI) in Diagnostics Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Artificial Intelligence (AI) in Diagnostics Market Key Factors Analysis
6. Artificial Intelligence (AI) in Diagnostics Market Porter's Five Forces Analysis
7. Artificial Intelligence (AI) in Diagnostics Market Assessment
8. Artificial Intelligence (AI) in Diagnostics Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.